Annals of Gastroenterological Surgery (Nov 2024)

Essential updates 2022–2023: Surgical and adjuvant therapies for locally advanced colorectal cancer

  • Yoshiki Kajiwara,
  • Hideki Ueno

DOI
https://doi.org/10.1002/ags3.12853
Journal volume & issue
Vol. 8, no. 6
pp. 977 – 986

Abstract

Read online

Abstract Pivotal articles that had been published between 2022 and 2023 on surgical and perioperative adjuvant treatments for locally advanced colorectal cancer (CRC) were reviewed. This review focuses on new evidence in the following areas: optimization of surgical procedures for colon cancer, including the optimal length of bowel resection and use of the no‐touch isolation technique; minimally invasive surgery for rectal cancer, such as laparoscopic transanal total mesorectal excision and robotic surgery; neoadjuvant treatments for rectal cancer, including total neoadjuvant therapy; neoadjuvant chemotherapy for colon cancer; and postoperative adjuvant chemotherapy for Stage II and III colon cancer. Although the current understanding may not enable perfect decision‐making for patients and medical professionals, ongoing advancements are expected to result in more effective personalized treatment plans, ultimately improving the prognosis and quality of life of patients.

Keywords